Literature DB >> 22244005

GeneXpert in the diagnosis of risk factors for thrombophilia: evaluation of its use in a small laboratory.

Gianluca Gessoni, Sara Valverde Sara, Rosa Canistro, Fabio Manoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22244005      PMCID： PMC3320786          DOI： 10.2450/2011.0077-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

1.  Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction.

Authors:  Peter C Cooper; Susan M Cooper; Julie M Smith; Steven Kitchen; Michael Makris
Journal:  Blood Coagul Fibrinolysis       Date:  2003-07       Impact factor: 1.276

2.  Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population.

Authors:  Gianluca Gessoni; Sara Valverde; Rosa Canistro; Fabio Manoni
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

Review 3.  Inherited thrombophilia.

Authors:  Massimo Franchini; Dino Veneri; Gian Luca Salvagno; Franco Manzato; Giuseppe Lippi
Journal:  Crit Rev Clin Lab Sci       Date:  2006       Impact factor: 6.250

4.  Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

Authors:  Siva Raja; Jesus Ching; Liqiang Xi; Steven J Hughes; Ronald Chang; Wendy Wong; William McMillan; William E Gooding; Kenneth S McCarty; Melissa Chestney; James D Luketich; Tony E Godfrey
Journal:  Clin Chem       Date:  2005-03-03       Impact factor: 8.327
  4 in total
  2 in total

1.  Futility of testing for factor V Leiden.

Authors:  Emmanuel J Favaloro; David McDonald
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

Review 2.  Utility of testing for factor V Leiden.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.